Skip to main navigation Skip to search Skip to main content

Tralokinumab monotherapy for moderate-to-severe atopic dermatitis

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date10/31/17 → 07/31/21

Funding

  • Leo Pharma Incorporated: $36,676.00